COMMUNIQUÉS West-GlobeNewswire

First Choice Healthcare Solutions to Host Second Quarter 2018 Results Conference Call on August 15, 2018

13/08/2018 - 14:30

MELBOURNE, Fla., Aug. 13, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS ) ("First Choice" or the "Company"), a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 10 August 2018

13/08/2018 - 14:11

Bagsværd, Denmark, 13 August 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]

Transactions under Novozymes’ stock buyback program

13/08/2018 - 14:02

Please read the full announcement in the attached PDF Attachment 2018_48_Stock_Buybackprogram_EN

Allscripts Payerpath™ Achieves EHNAC Healthcare Network Accreditations

13/08/2018 - 14:01

Both HNAP and APAP accreditations ensure adherence to health data processing standards and compliance with security infrastructure and integrity requirements CHICAGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ [...]

CTD Holdings Announces Expanded Access Protocol using Intravenous Trappsol® Cyclo™ for Alzheimer’s Disease

13/08/2018 - 14:00

Protocol Available on ClinicalTrials.gov ALACHUA, Fla., Aug. 13, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the [...]

Sun BioPharma, Inc. Provides a Business Update and Files Report for Q2 2018

13/08/2018 - 14:00

First Patients Enrolled in Front-Line Combination Study of SBP-101 with Gemcitabine and nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer Additional Funds Raised during Q2 MINNEAPOLIS, Aug. 13, 2018 ( [...]

HealthEC Launches Opioid Analytics Module at 2018 MESC Conference

13/08/2018 - 14:00

New solution tackles key opioid-addiction issues state Medicaid agencies will be addressing at Medicaid Enterprise Systems Conference EDISON, N.J., Aug. 13, 2018 (GLOBE NEWSWIRE) -- HealthEC , a KLAS-recognized end-to- [...]

Catalyst Biosciences Announces Oral Presentation at the 2018 Hemophilia Drug Development Summit

13/08/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]

Arsanis Reports Financial Results for Second Quarter 2018

13/08/2018 - 14:00

WALTHAM, Mass. and VIENNA, Austria, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Arsanis, Inc. (NASDAQ: ASNS), a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address [...]

BioSig Technologies Completes Private Placement

13/08/2018 - 14:00

Capital Raised to Support Nasdaq Uplist and Commercial Launch Santa Monica, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical [...]

Mustang Bio and St. Jude Children’s Research Hospital Enter into Exclusive Worldwide License Agreement for a Ground-Breaking, Clinical-Stage Lentiviral Gene Therapy with Curative Potential for X-linked Severe Combined Immunodeficiency

13/08/2018 - 14:00

Mustang Expands Pipeline into Gene Therapy for Rare Disease NEW YORK and MEMPHIS, Tenn., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a Fortress Biotech (NASDAQ: FBIO) Company focused [...]

Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer

13/08/2018 - 14:00

NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]

Xeris Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Highlights

13/08/2018 - 14:00

Successfully Completed Initial Public Offering (IPO) Submitted New Drug Application (NDA) for Glucagon Rescue Pen CHICAGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty [...]

Cellectar’s CLR 131 Receives FDA Rare Pediatric Disease Designation for the Treatment of Ewing’s Sarcoma

13/08/2018 - 14:00

MADISON, Wis., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]

SoldierStrong Donates Exoskeleton for Advanced Stroke Rehabilitation to Tampa’s James A. Haley Veterans' Hospital

13/08/2018 - 14:00

Tampa-area veterans now have access to earlier mobilization following a stroke STAMFORD, Conn., Aug. 13, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit organization dedicated to providing advanced medical [...]

Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2018

13/08/2018 - 13:30

HOUSTON, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

Nephros Appoints Oliver Spandow to its Board of Directors

13/08/2018 - 13:30

Seasoned Executive Adds Significant Operational and M&A Expertise SOUTH ORANGE, NJ, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells [...]

Athenex Pharma Solutions, an Athenex, Inc. Company, Launches Compounded Vasopressin Injection in Ready-to-Use Premix IV Bags

13/08/2018 - 13:29

BUFFALO, N.Y., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Health Care Services Business in New England, U.S.

13/08/2018 - 13:29

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), is [...]